Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
about
Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells.Harnessing the immune system in the battle against breast cancer.Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors.The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer
P2860
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@en
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@nl
type
label
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@en
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@nl
prefLabel
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@en
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@nl
P2093
P2860
P50
P1433
P1476
Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.
@en
P2093
Andrea L Richardson
Anne Trinh
Carlos R Gil Del Alcazar
Charles H McDonnell
D Craig Allred
Deborah Dillon
Elizabeth Min Hui Kim
Franziska Michor
Gordon J Freeman
Helga Bergholtz
P2860
P304
P356
10.1158/2159-8290.CD-17-0222
P577
2017-06-26T00:00:00Z